Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-11-18

Clinical Trial Update: Study In Patients With Overactive Bladder Treated With Toviaz® After Failure Of Previous Therapy

View source ↗

Summary

Clinical trial update for patients with overactive bladder treated with Toviaz after failure of previous therapy; study status completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Toviaz (fesoterodine fumarate)

Snippet

Sponsor: Pfizer | Conditions: Overactive Bladder, Urinary Incontinence | Status: COMPLETED | Results posted: 2010-11-18